Use of vildagliptin and sulfonylurea therapy, with and without metformin,in Indian patients with type 2 diabetes mellitus during the Ramadan fast.

Trial Profile

Use of vildagliptin and sulfonylurea therapy, with and without metformin,in Indian patients with type 2 diabetes mellitus during the Ramadan fast.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2011

At a glance

  • Drugs Metformin; Sulfonylureas; Vildagliptin
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top